06212016 679 58 vehik diab care 2016 0
Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study Reversion of b-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study DOI: 10.2337/dc16-0181 OBJECTIVE b-Cell autoantibodies are a feature of the preclinical phase of type 1 diabetes. Here, we asked how frequently they revert in a cohort of children at risk for type 1 diabetes and whether reversion has any effect
https://www.teddy.lu.se/sites/teddy.lu.se/files/06212016_679_58_vehik_diab_care_2016_0.pdf - 2025-11-04
